Smad2/3信号通路介导体外声带成肌细胞的萎缩反应
本研究为体外实验,将大鼠甲杓肌来源的成肌细胞分化为肌管,分别加入肌肉生长抑制素或TGF-β1,并观察ALK4/5抑制剂或Smad2/3 siRNA的干预效果。结果显示肌肉生长抑制素和TGF-β1均抑制成肌分化并激活Smad2/3信号,且TGF-β1的效应比肌肉生长抑制素更明显,上述效应可被ALK4/5抑制剂逆转。作者认为Smad2/3可能成为声带肌肉萎缩有吸引力的治疗靶点。
要点
- 肌肉生长抑制素和TGF-β1均抑制大鼠声带成肌细胞的分化并增加Smad2/3核内强度。
- TGF-β1引起的萎缩相关反应比肌肉生长抑制素更明显,且可被ALK4/5抑制剂逆转。
- Smad2/3 siRNA敲低促进成肌分化,支持Smad2/3信号在声带成肌细胞萎缩反应中的作用。
核心结论
- Smad2/3信号介导声带成肌细胞的分化,TGF-β1引起的萎缩反应比肌肉生长抑制素更明显,Smad2/3可能是声带肌肉萎缩有吸引力的治疗靶点。
研究设计与样本
- 体外研究,使用从大鼠甲杓肌分离的成肌细胞,在成肌分化培养基中±500 ng/mL肌肉生长抑制素或10 ng/mL TGF-β1,并联合或不联合ALK4/5抑制剂或靶向Smad2和Smad3的siRNA。
- 通过免疫荧光评估肌管形成和Smad2/3激活(Smad2/3核内定位),通过qRT-PCR定量肌管分化和Smad2/3信号相关转录。
主要发现
- 肌肉生长抑制素和TGF-β1均抑制成肌分化、增加Smad2/3核内强度、下调Myh2,并上调Smad2/3下游靶点Ccn2和Serpine1以及萎缩相关基因Fbox32。
- 上述效应在TGF-β1处理时比肌肉生长抑制素处理时更明显,并可被ALK4/5抑制剂逆转。
- 通过siRNA敲低Smad2/3促进成肌分化,进一步支持Smad2/3信号在声带成肌细胞萎缩反应中的作用。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: Vocal fold (VF) muscle atrophy, often associated with neuromuscular disorders and aging, can lead to voice-related disability. Myostatin is well-known to mediate skeletal muscle atrophy via Smad2/3 signaling, whereas TGF-β1, a potent inducer of Smad2/3 signaling, is upregulated following VF injury. However, the impact of Smad2/3 signaling on laryngeal muscles remains unclear. This study provides foundational insight regarding Smad2/3-dependent atrophic responses of VF skeletal muscle cells, to ultimately develop novel therapeutic strategies for VF muscle atrophy. STUDY DESIGN: In vitro. METHODS: Myoblasts isolated from the rat thyroarytenoid muscle were differentiated into myotubes in myogenic differentiation medium ±500 ng/mL myostatin or 10 ng/mL TGF-β1, in the presence or absence of an ALK4/5 inhibitor or siRNA targeting Smad2 and Smad3. Myotube formation and activation of Smad2/3 (nuclear localization of Smad2/3) were assessed via immunofluorescence. Transcription related to myotube differentiation and Smad2/3 signaling was quantified by qRT-PCR. RESULTS: Both myostatin and TGF-β1 suppressed myogenic differentiation, increased Smad2/3 nuclear intensity, downregulated Myh2, and upregulated downstream targets of Smad2/3 (Ccn2 and Serpine1) and Fbox32, an atrophy-related gene. These effects were more pronounced with TGF-β1 than with myostatin and were reversed by inhibition of ALK4/5. Furthermore, Smad2/3 knockdown via siRNA promoted myogenic differentiation, further supporting the role of Smad2/3 signaling in the atrophic response in VF myoblasts. CONCLUSIONS: Smad2/3 signaling mediates differentiation of VF myoblasts and TGF-β1, a potent mediator of fibrosis, elicited a more pronounced atrophic response than myostatin. Smad2/3 may be an attractive therapeutic target for VF muscle atrophy. LEVEL OF EVIDENCE: NA.
引用
- Yoshimatsu M, Nakamura R, Bing R, et al. Smad2/3 Signaling Mediates the Atrophic Response in Vocal Fold Myoblasts In Vitro. Laryngoscope. 2025. PMID: 40735858. doi:10.1002/lary.32474
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。